ClinicalTrials.gg
RecruitingNCT06596174Updated Nov 26, 2024

Effect of tSCS on Ankle Movement Training in Individuals With SCI

An interventional study of Transcutaneous spinal cord stimulation (tSCS) and Short-term Machine-Assisted Ankle Movement Training with tSCS in SCI - Spinal Cord Injury, sponsored by Chang Gung University. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-26.

Sponsored by Chang Gung University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Spinal Cord Injuries with a site in Taiwan — 9 open to participants now, 9 under way, none of them phase 3. Spinal Cord Injuries · Taiwan.

Planned enrollment
4th of 22
80 · median 20
Started
2024
with 4 others
No phase
17 of 31
7 open now
Registered
26th of 31
by date
Lead sponsor
5 of 31
Chang Gung University

Among the 31 studies in Spinal Cord Injuries with a site in Taiwan, this one is the 4th largest by planned enrollment of the 22 interventional ones that give a count, is one of 5 that started in 2024, is one of 17 with no phase, and was the 26th registered.

Spinal Cord Injuries

2,031 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

9 of the 31 studies in Spinal Cord Injuries with a site in Taiwan are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 20 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Spinal Cord Injuries with a site in Taiwan, or all of them as a file.
02

Study summary

This clinical trial explores the effectiveness of transcutaneous spinal cord stimulation (tSCS), a non-invasive technique, in facilitating spinal circuitry adaptation in individuals with spinal cord injury (SCI). While epidural spinal cord stimulation (eSCS) has shown functional benefits, its application is limited by the side effects associated with implanted electrodes. tSCS, which shares a similar mechanism but does not require surgery, has yet to be extensively studied in large human trials.

The study aims to:

Determine optimal tSCS parameters for non-invasive spinal stimulation. Investigate the priming effect of tSCS on spinal circuitry during machine-assisted ankle movement training.

Examine the long-term clinical outcomes of combining tSCS with ankle movement training in individuals with incomplete SCI.

The trial will include both healthy participants and individuals with complete and incomplete SCI, using the soleus post-activation depression (PAD) model to evaluate spinal circuitry adaptation. The results will provide insights into spinal re-adaptation and potentially introduce a novel, non-invasive approach for SCI rehabilitation.

03

Conditions studied

  • SCI - Spinal Cord Injury

Keywords

  • post activation depression
  • transcutaneous spinal cord electrical stimulation (tSCS)
  • machine-assist therapy
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Health subjects:

Exclusion Criteria:

  1. Musculoskeletal injuries on legs.
  2. Osteoporosis.

SCI subjects:

Inclusion Criteria

  1. Participants with chronic spinal cord injury, with injury duration greater than one year.

Exclusion Criteria

  1. Current musculoskeletal or joint injuries in the lower limbs.
  2. History of central or peripheral neuromuscular diseases.
  3. Presence of a pacemaker.
  4. Current use of antispastic or antidepressant medications.
  5. Current venous thromboembolism or osteoporosis.
  6. Impairment of the soleus H-reflex arc.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Stage 1: Healthy people

    Identify optimal tSCS parameters for non-invasive spinal stimulation.

    Procedure: Transcutaneous spinal cord stimulation (tSCS)

  • Experimental
    Stage 2: SCI Patients

    Assess the priming effect of tSCS on spinal circuitry during machine-assisted ankle movement training.

    Procedure: Short-term Machine-Assisted Ankle Movement Training with tSCS

  • Experimental
    Stage 3:SCI Patients

    Long-term clinical effects of combined tSCS and ankle movement training

    Procedure: Long-term Effects of Machine-Assisted Ankle Movement Training with tSCS

  • No intervention
    Stage 3:SCI Patients(Control)

    Control Group

Interventions

  • ProcedureTranscutaneous spinal cord stimulation (tSCS)

    The subjects will undergo 20 minutes transcutaneous spinal cord stimulation (tSCS).

  • ProcedureShort-term Machine-Assisted Ankle Movement Training with tSCS

    The subjects will undergo 30 minutes of machine-assisted ankle movement training combined with transcutaneous spinal cord stimulation (tSCS) at a time

  • ProcedureLong-term Effects of Machine-Assisted Ankle Movement Training with tSCS

    The subjects will undergo machine-assisted ankle movement training combined with transcutaneous spinal cord stimulation (tSCS). Each session will last for 30 minutes, conducted three times per week, over a period of four weeks.

06

What researchers measure

Primary outcomes

  1. Latency and amplitude of the H-reflex

    The H-reflex will be elicited through electrical stimulation of the tibial nerve (or sciatic nerve) using electromyography (EMG) to record the resulting muscle response.

    Time frame: Baseline, 4 weeks

  2. Latency, amplitude, and duration of the M-wave

    The M-wave will be elicited by direct electrical stimulation of the motor nerve (e.g., tibial nerve) and recorded using electromyography (EMG) from the target muscle (e.g., soleus muscle).

    Time frame: Baseline, 4 weeks

  3. Level of Post-Activation Depression (PAD) of the H-reflex

    The H-reflex will be elicited by electrical stimulation of the tibial nerve (or other motor nerves), and PAD will be assessed by measuring the reduction in H-reflex amplitude following a series of repetitive stimuli. The amplitude of the H-reflex after repeated stimulation will be compared to the baseline single stimulus.

    Time frame: Baseline, 4 weeks

  4. Latency and amplitude of the Posterior Root Muscle (PRM) reflex

    The PRM reflex will be elicited by stimulating the posterior roots of the spinal cord (typically via electrical stimulation of the dorsal roots), and the resulting muscle activity will be recorded using electromyography (EMG)

    Time frame: Baseline, 4 weeks

  5. Muscle spasticity levels as assessed by the Modified Ashworth Scale (MAS).

    Muscle spasticity will be evaluated using the MAS, which grades the resistance encountered during passive movement of the affected limb (e.g., arm or leg). The scale ranges from 0 (no increase in muscle tone) to 4 (affected part rigid in flexion or extension).

    Time frame: Baseline, 4 weeks

  6. Muscle Tone (Frequency, Hz)

    This parameter measures the natural oscillation frequency of the muscle in response. It reflects the muscle's state of tension or readiness.

    Time frame: Baseline, 4 weeks

  7. Elasticity (Dynamic Stiffness, N/m)

    Elasticity, measured in Newtons per meter, reflects the muscle's ability to return to its original shape after being deformed by the impulse

    Time frame: Baseline, 4 weeks

  8. Stiffness (Decay, ms)

    This parameter quantifies the rate at which the muscle returns to its initial state after the impulse, indicating the muscle's stiffness

    Time frame: Baseline, 4 weeks

  9. Mechanical Stress (Creep, s) and Relaxation (S)

    These parameters measure the time it takes for muscle tissue to adapt to a sustained force (creep) and the time it takes for the muscle to return to a relaxed state after removing the force (relaxation).

    Time frame: Baseline, 4 weeks

Secondary outcomes

  1. Foot pressure distribution and peak pressure.

    Foot pressure will be measured using pressure sensors during ankle movement

    Time frame: Measured continuously during CPM

  2. The score of 10-meter walking test (10MWT)

    To measure walking speed over a short distance as a quantitative index of walking ability.

    Time frame: Baseline, 4 weeks.

  3. Ankle Joint Range of Motion (ROM)

    These movements measure the ability to move the foot up towards the shin (dorsiflexion) and down away from the body (plantarflexion). Typical instruments used include a universal goniometer or an inclinometer. The patient is typically seated or lying down with the knee extended for accurate measurement.

    Time frame: Baseline, 4 weeks

  4. Knee Joint ROM

    These are the primary movements of the knee, involving bending (flexion) and straightening (extension) of the leg. Measurements are taken with the patient seated or lying down. A goniometer is placed on the lateral aspect of the knee to record the angle of maximum bend and extension.

    Time frame: Baseline, 4 weeks

  5. Overall the Patient Reported Impact of Spasticity Measure(PRISM) Score

    An aggregated score derived from all the individual items within the questionnaire, providing a comprehensive measure of the impact of spasticity on the patient's quality of life

    Time frame: Baseline, 4 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Aug 2026, 21 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 21 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2024
First posted
Sep 19, 2024
StartActual
Nov 25, 2024
Primary completionEst.
Aug 2026
CompletionEst.
Aug 2026
Last update
Nov 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06596174
Lead sponsor
Chang Gung University
Responsible party
Ya-Ju Chang (Professor, Chang Gung University) — Principal investigator
First posted
Sep 19, 2024
Start date
Nov 25, 2024
Primary completion
Aug 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Nov 26, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion